Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma

doi:10.3748/wjg.v25.i37.5655

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7192)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

358

WORD

215

HTML

3303

Figures (1-4)

289

Tables (1-3)

286

Sum=4451

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

864

Download

1877

Sum=2741

Oct 7, 2019 (publication date) through Feb 17, 2025

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 7, 2019; 25(37): 5655-5666
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5655

Full Size Figure Download Figure

Figure 3 Overall survival curve with different adjuvant therapies for patients with advanced gallbladder adenocarcinoma. CTx: Adjuvant chemotherapy; XRT: Adjuvant radiotherapy; cXRT: Adjuvant chemoradiotherapy.

Citation: Geng ZM, Cai ZQ, Zhang Z, Tang ZH, Xue F, Chen C, Zhang D, Li Q, Zhang R, Li WZ, Wang L, Si SB. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma. World J Gastroenterol 2019; 25(37): 5655-5666
URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5655.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5655